Literature DB >> 27446989

Induced regulatory T cells in allograft tolerance via transient mixed chimerism.

Kiyohiko Hotta1, Akihiro Aoyama1, Tetsu Oura1, Yohei Yamada1, Makoto Tonsho1, Kyu Ha Huh1, Kento Kawai1, David Schoenfeld2, James S Allan1, Joren C Madsen1, Gilles Benichou1, Rex-Neal Smith3, Robert B Colvin3, David H Sachs1, A Benedict Cosimi1, Tatsuo Kawai1.   

Abstract

Successful induction of allograft tolerance has been achieved in nonhuman primates (NHPs) and humans via induction of transient hematopoietic chimerism. Since allograft tolerance was achieved in these recipients without durable chimerism, peripheral mechanisms are postulated to play a major role. Here, we report our studies of T cell immunity in NHP recipients that achieved long-term tolerance versus those that rejected the allograft (AR). All kidney, heart, and lung transplant recipients underwent simultaneous or delayed donor bone marrow transplantation (DBMT) following conditioning with a nonmyeloablative regimen. After DBMT, mixed lymphocyte culture with CFSE consistently revealed donor-specific loss of CD8+ T cell responses in tolerant (TOL) recipients, while marked CD4+ T cell proliferation in response to donor antigens was found to persist. Interestingly, a significant proportion of the proliferated CD4+ cells were FOXP3+ in TOL recipients, but not in AR or naive NHPs. In TOL recipients, CD4+FOXP3+ cell proliferation against donor antigens was greater than that observed against third-party antigens. Finally, the expanded Tregs appeared to be induced Tregs (iTregs) that were converted from non-Tregs. These data provide support for the hypothesis that specific induction of iTregs by donor antigens is key to long-term allograft tolerance induced by transient mixed chimerism.

Entities:  

Year:  2016        PMID: 27446989      PMCID: PMC4951099          DOI: 10.1172/jci.insight.86419

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  42 in total

Review 1.  Strategies to improve long-term outcomes after renal transplantation.

Authors:  Manuel Pascual; Tom Theruvath; Tatsuo Kawai; Nina Tolkoff-Rubin; A Benedict Cosimi
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

2.  Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.

Authors:  Eva Krystufkova; Alena Sekerkova; Ilja Striz; Irena Brabcova; Eva Girmanova; Ondrej Viklicky
Journal:  Nephrol Dial Transplant       Date:  2011-12-13       Impact factor: 5.992

3.  CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates.

Authors:  Tatsuo Kawai; Hiroshi Sogawa; Svetlan Boskovic; Gregory Abrahamian; Rex-Neal Smith; Siew-Lin Wee; David Andrews; Ognjenka Nadazdin; Ichiro Koyama; Megan Sykes; Henry J Winn; Robert B Colvin; David H Sachs; A Benedict Cosimi
Journal:  Am J Transplant       Date:  2004-09       Impact factor: 8.086

4.  Comprehensive characterization of MHC class II haplotypes in Mauritian cynomolgus macaques.

Authors:  Shelby L O'Connor; Alex J Blasky; Chad J Pendley; Ericka A Becker; Roger W Wiseman; Julie A Karl; Austin L Hughes; David H O'Connor
Journal:  Immunogenetics       Date:  2007-03-24       Impact factor: 2.846

5.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; David H Sachs; Megan Sykes; A Benedict Cosimi
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

6.  Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: characterization, isolation, and regulation of MHC class II expression.

Authors:  Kimberly A Muczynski; David M Ekle; David M Coder; Susan K Anderson
Journal:  J Am Soc Nephrol       Date:  2003-05       Impact factor: 10.121

Review 7.  Once a Treg, always a Treg?

Authors:  Deepali V Sawant; Dario A A Vignali
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

8.  Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody.

Authors:  A B Cosimi; F L Delmonico; J K Wright; S L Wee; F I Preffer; L K Jolliffe; R B Colvin
Journal:  Surgery       Date:  1990-08       Impact factor: 3.982

9.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; A Benedict Cosimi; Thomas R Spitzer; Nina Tolkoff-Rubin; Manikkam Suthanthiran; Susan L Saidman; Juanita Shaffer; Frederic I Preffer; Ruchuang Ding; Vijay Sharma; Jay A Fishman; Bimalangshu Dey; Dicken S C Ko; Martin Hertl; Nelson B Goes; Waichi Wong; Winfred W Williams; Robert B Colvin; Megan Sykes; David H Sachs
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

10.  Genomic responses in mouse models poorly mimic human inflammatory diseases.

Authors:  Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

View more
  22 in total

1.  Twenty-year Follow-up of Histocompatibility Leukocyte Antigen-matched Kidney and Bone Marrow Cotransplantation for Multiple Myeloma With End-stage Renal Disease: Lessons Learned.

Authors:  Thomas R Spitzer; Nina Tolkoff-Rubin; A Benedict Cosimi; Steven McAfee; Bimalangshu R Dey; Yi-Bin Chen; Francis Delmonico; Megan Sykes; David H Sachs; Tatsuo Kawai
Journal:  Transplantation       Date:  2019-11       Impact factor: 4.939

2.  Long-term Nonhuman Primate Renal Allograft Survival Without Ongoing Immunosuppression in Recipients of Delayed Donor Bone Marrow Transplantation.

Authors:  Kiyohiko Hotta; Tetsu Oura; Abbas Dehnadi; Svjetlan Boskovic; Masatoshi Matsunami; Ivy Rosales; Rex N Smith; Robert B Colvin; A Benedict Cosimi; Tatsuo Kawai
Journal:  Transplantation       Date:  2018-04       Impact factor: 4.939

Review 3.  Preclinical and clinical studies for transplant tolerance via the mixed chimerism approach.

Authors:  Hajime Sasaki; Tetsu Oura; Thomas R Spitzer; Yi-Bin Chen; Joren C Madsen; James Allan; David H Sachs; A B Cosimi; Tatsuo Kawai
Journal:  Hum Immunol       Date:  2017-11-22       Impact factor: 2.850

Review 4.  Advances in the immunology of heart transplantation.

Authors:  Joren C Madsen
Journal:  J Heart Lung Transplant       Date:  2017-10-20       Impact factor: 10.247

5.  Transient Mixed Chimerism With Nonmyeloablative Conditioning Does Not Induce Liver Allograft Tolerance in Nonhuman Primates.

Authors:  Sulemon Chaudhry; Yojiro Kato; Joshua Weiner; Paula Alonso-Guallart; Sam Baker; David C Woodland; Jay H Lefkowitch; Raimon Duran-Struuck; Hugo P Sondermeijer; Jonah Zitsman; Mallory L Sears; Anette Wu; Brian Karolewski; Philipp J Houck; Mercedes Martinez; Tomoaki Kato; Megan Sykes; Adam D Griesemer
Journal:  Transplantation       Date:  2020-04-06       Impact factor: 4.939

Review 6.  Mechanisms of Mixed Chimerism-Based Transplant Tolerance.

Authors:  Julien Zuber; Megan Sykes
Journal:  Trends Immunol       Date:  2017-08-18       Impact factor: 16.687

Review 7.  Chimerism-based tolerance in organ transplantation: preclinical and clinical studies.

Authors:  T Oura; A B Cosimi; T Kawai
Journal:  Clin Exp Immunol       Date:  2017-04-20       Impact factor: 4.330

8.  Long-term Kinetics of Intragraft Gene Signatures in Renal Allograft Tolerance Induced by Transient Mixed Chimerism.

Authors:  Masatoshi Matsunami; Ivy A Rosales; Benjamin A Adam; Tetsu Oura; Michael Mengel; Rex-Neal Smith; Hang Lee; A Benedict Cosimi; Robert B Colvin; Tatsuo Kawai
Journal:  Transplantation       Date:  2019-11       Impact factor: 4.939

9.  Transplantation tolerance through mixed chimerism: From allo to xeno.

Authors:  David H Sachs
Journal:  Xenotransplantation       Date:  2018-05       Impact factor: 3.907

10.  Addition of Anti-CD40 Monoclonal Antibody to Nonmyeloablative Conditioning With Belatacept Abrogated Allograft Tolerance Despite Induction of Mixed Chimerism.

Authors:  Tetsu Oura; Kiyohiko Hotta; Ivy Rosales; Abbas Dehnadi; Kent Kawai; Hang Lee; A Benedict Cosimi; Tatsuo Kawai
Journal:  Transplantation       Date:  2019-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.